Home › Funds › Sanofi › ANAB

Sanofi position in ANAB

ANAPTYSBIO INC · Health Care

Sanofi reported holding 821,917 shares of ANAB (ANAPTYSBIO INC) in its Q3 2026 13F filing — a position valued at US$41.3M, representing 6.56% of its reported portfolio and ranking #6 among its reported holdings. Sanofi has disclosed ANAB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)821.92K sh
Reported value held$41.31M
Portfolio Weight6.56%
First reportedQ4 2024
Last changeHold
Updated2026-11-05

Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR

How Sanofi's ANAB position evolved

Sanofi first disclosed a stake in ANAB in Q4 2024 at 821,917 shares (US$10.9M). The position peaked in Q2 2026 at 821,917 shares, worth US$55.5M. Across 8 filings, Sanofi held the position steady without any share-count change. The most recent filing (Q3 2026) shows 821,917 shares valued at US$41.3M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 821.92K $10.88M New
Q1 2025 821.92K $15.28M Hold
Q2 2025 821.92K $18.25M Hold
Q3 2025 821.92K $25.17M Hold
Q4 2025 821.92K $39.85M Hold
Q1 2026 821.92K $30.38M Hold
Q2 2026 821.92K $55.48M Hold
Q3 2026 821.92K $41.31M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANAB and 13F data

ANAB (ANAPTYSBIO INC) is a Health Care company. 46 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$531.9M), TANG CAPITAL MANAGEMENT LLC (US$89.8M), Affinity Asset Advisors, LLC (US$55.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANAB

All ANAB fund holders →

FAQ

How long has Sanofi held ANAB?

Sanofi has disclosed ANAB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Sanofi's current position in ANAB?

As of Q3 2026, Sanofi holds 821.92K shares of ANAB (ANAPTYSBIO INC), valued at $41.31M, representing 6.56% of its reported portfolio and ranking #6.

Has Sanofi been buying or selling ANAB?

In the latest 13F filing (Q3 2026), Sanofi held unchanged its position in ANAB. The position peaked in Q2 2026 at 821.92K shares.

Which other funds hold ANAB?

Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Affinity Asset Advisors, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.